Medtrum

About:

Medtrum is a diabetes management medical device developer.

Top Investors: HongShan, 3E Bioventures, Bank of China Group Investment, Shanghai Nuokai Investment Management, ZJ Innopark (Zhangjiang Hi-Tech Park)

Description:

Medtrum is a company dedicated to simplifying diabetes management. They develop and deliver medical devices that meet the needs of patients with different types of diabetes, create tools to bring convenience to healthcare professionals, and explore the frontiers in artificial pancreas research.

Total Funding Amount:

$29.1M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2008-01-01

Contact Email:

info(AT)medtrum.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2018-12-25

IPO Status:

Private

Industries: